Literature DB >> 25977163

Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-naïve HIV patients.

Apostolos Karavidas1, George Xylomenos2, Vassiliki Matzaraki1, Nikolaos Papoutsidakis1, Georgios Leventopoulos1, Dimitrios Farmakis3, George Lazaros1, Anastasia Perpinia1, Sophia Arapi1, Nikolaos Paisios2, John Parissis4, Vlasios Pyrgakis1, Panagiotis Gargalianos2.   

Abstract

BACKGROUND: Patients infected by the human immunodeficiency virus (HIV) and receiving highly active antiretroviral therapy have a higher incidence of cardiovascular disease than healthy subjects, but little is known about cardiac function in asymptomatic and treatment-naïve patients. We sought to study cardiac function in asymptomatic HIV-infected, treatment-naïve patients.
METHODS: We studied 41 HIV-infected and treatment-naïve patients and 20 age- and sex-matched healthy controls. Patients with cardiac symptoms, history of cardiac disease or NT-proBNP >100 pg/mL were excluded. We addressed cardiac function using standard echocardiography along with tissue Doppler (TDI) measurements, including strain/strain rate assessment.
RESULTS: Standard echocardiographic parameters did not differ between groups, except for transmitral E wave velocity (64.8 ± 14 cm/s in HIV vs 76.1 ± 10 cm/s in controls, p = 0.002). In contrast, TDI mitral and tricuspid annulus s velocity and all strain/strain rate measurements were significantly lower in HIV patients: s lateral, 10.2 ± 2.4/11.3 ± 0.7, p = 0.011; s septal, 8.1 ± 1.6/8.7 ± 0.8, p = 0.045; s tricuspid, 13.4 ± 2.3/14.9 ± 1.3, p = 0.002; strain/strain rate, septal (strain/strain rate, 15.1 ± 5.7/-0.9 ± 0.3, 25.3 ± 1.7/-1.9 ± 0.2, p < 0.001), anterior (16.7 ± 3/-1.0 ± 0.1, 26.7 ± 1.7/-1.9 ± 0.2, p < 0.001), lateral (16.0 ± 6/-1.0 ± 0.1, 27.5 ± 1.8/-2.2 ± 0.3, p < 0.001) and posterior (15.2 ± 5.8/-1.0 ± 0.2, 26.2 ± 1.8/-2.2 ± 0.3, p < 0.001) left ventricular wall.
CONCLUSIONS: HIV infection itself is accompanied by subclinical systolic dysfunction, not apparent to standard echocardiography that can be unmasked though using sensitive echocardiographic techniques.

Entities:  

Keywords:  HIV; Myocardial deformation; Strain; Strain rate; Systolic dysfunction

Mesh:

Year:  2015        PMID: 25977163     DOI: 10.1007/s00392-015-0866-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  25 in total

1.  Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors.

Authors:  Fenneke C P Frerichs; Koert P Dingemans; Kees Brinkman
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.

Authors:  Stacy D Fisher; Brinder S Kanda; Tracie L Miller; Steven E Lipshultz
Journal:  Am J Cardiovasc Drugs       Date:  2011-12-01       Impact factor: 3.571

Review 3.  Echocardiographic assessment of myocardial strain.

Authors:  John Gorcsan; Hidekazu Tanaka
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

Review 4.  Emerging clinical role of strain imaging in echocardiography.

Authors:  Dominic Y Leung; Arnold C T Ng
Journal:  Heart Lung Circ       Date:  2010-02-09       Impact factor: 2.975

5.  Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach.

Authors:  Johannes H Riffel; Marius G P Keller; Matthias Aurich; Yannick Sander; Florian Andre; Sorin Giusca; Fabian Aus dem Siepen; Sebastian Seitz; Christian Galuschky; Grigorios Korosoglou; Derliz Mereles; Hugo A Katus; Sebastian J Buss
Journal:  Clin Res Cardiol       Date:  2015-02-03       Impact factor: 5.460

6.  Myocarditis and cardiomyopathy HIV associated.

Authors:  Salvatore Patanè; Filippo Marte; Mauro Sturiale; Giuseppe Dattilo; Antonio Albanese
Journal:  Int J Cardiol       Date:  2009-01-30       Impact factor: 4.164

7.  Myocardial dysfunction in patients infected with HIV: prevalence and risk factors.

Authors:  A J Jacob; G R Sutherland; A G Bird; R P Brettle; C A Ludlam; A McMillan; N A Boon
Journal:  Br Heart J       Date:  1992-12

8.  Assessment of cardiac function with Doppler tissue imaging in asymptomatic HIV-infected patients.

Authors:  Apostolos Karavidas; Manolis Foukarakis; George Lazaros; Maria Chini; Ioannis Fotiadis; Sophia Arapi; Theodoros Gialernios; Nicolaos Potamitis; Panos Gargalianos; Evangellos Matsakas; Christodoulos Stefanadis
Journal:  Int J STD AIDS       Date:  2008-04       Impact factor: 1.359

Review 9.  HIV and coronary heart disease: time for a better understanding.

Authors:  Franck Boccara; Sylvie Lang; Catherine Meuleman; Stephane Ederhy; Murielle Mary-Krause; Dominique Costagliola; Jacqueline Capeau; Ariel Cohen
Journal:  J Am Coll Cardiol       Date:  2013-02-05       Impact factor: 24.094

10.  Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.

Authors:  Stefan Esser; Götz Gelbrich; Norbert Brockmeyer; Alexander Goehler; Dirk Schadendorf; Raimund Erbel; Till Neumann; Nico Reinsch
Journal:  Clin Res Cardiol       Date:  2012-11-02       Impact factor: 5.460

View more
  7 in total

1.  Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

Authors:  F Aus dem Siepen; R Bauer; A Voss; S Hein; M Aurich; J Riffel; D Mereles; C Röcken; S J Buss; H A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2017-09-27       Impact factor: 5.460

2.  Intra-procedural determination of viability by myocardial deformation imaging: a randomized prospective study in the cardiac catheter laboratory.

Authors:  Alexander Schuh; Vadim Karayusuf; Ertunc Altiok; Sandra Hamada; Jörg Schröder; Andras Keszei; Malte Kelm; Matias de la Fuente; Michael Frick; Klaus Radermacher; Nikolaus Marx; Michael Becker
Journal:  Clin Res Cardiol       Date:  2017-03-20       Impact factor: 5.460

3.  The hidden continuum of HIV-associated cardiomyopathy: A focussed review with case reports.

Authors:  Pieter-Paul S Robbertse; Anton F Doubell; Jean B Nachega; Philip G Herbst
Journal:  SA Heart J       Date:  2021-10-27

4.  Evaluation of Subtle Left Ventricular Systolic Dysfunction by Longitudinal Systolic Strain in Patients with Human Immunodeficiency Virus.

Authors:  Sukru Cetin; Alper Gündüz; Ayşe Şabablı Çetin; Ahmet Gurdal; Mutlu Çağan Sümerkan; Süleyman Sezai Yıldız; Nuray Uzun; Kadriye Orta Kilickesmez
Journal:  Acta Cardiol Sin       Date:  2018-07       Impact factor: 2.672

Review 5.  Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.

Authors:  Daniela Sofia Martins Pinto; Manuel Joaquim Lopes Vaz da Silva
Journal:  Curr Cardiol Rev       Date:  2018-03-14

6.  A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection.

Authors:  Prasanta K Dash; Fadhel A Alomar; Jesse L Cox; JoEllyn McMillan; Bryan T Hackfort; Edward Makarov; Brenda Morsey; Howard S Fox; Howard E Gendelman; Santhi Gorantla; Keshore R Bidasee
Journal:  Front Cardiovasc Med       Date:  2021-12-14

7.  Echocardiographic assessment of asymptomatic US Air Force members with early HIV infection.

Authors:  Gadiel R Alvarado; Courtney R Usry; Rosco S Gore; James A Watts; Jason F Okulicz
Journal:  BMC Res Notes       Date:  2019-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.